• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

R Package Adsasi Optimizes Clinical Trial Sample Sizes via Adaptive Simulation

by
November 20, 2026
in Health
Reading Time: 3 mins read
0
R Package Adsasi Optimizes Clinical Trial Sample Sizes via Adaptive Simulation

R Package Adsasi Optimizes Clinical Trial Sample Sizes via Adaptive Simulation

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A newly introduced open-source software package called adsasi provides a simulation-first framework for calculating sample sizes and optimizing study designs in experimental settings where analytical formulas are unavailable or impractical. Developed by researcher Skerdi Haviari and published in BMC Medical Research Methodology, the R package addresses an enduring methodological barrier in clinical trial design. Determining an adequate sample size is a foundational requirement for clinical trials and other empirical investigations, yet many modern study configurations cannot be resolved with tractable closed-form mathematical solutions.

Existing software tools developed for clinical trial simulation generally support scenario generation, but they offer limited utility for adaptive, empirically driven sample size optimization. To overcome these constraints, adsasi conducts simulation-first sample size estimation alongside design optimization for complex experimental protocols by adaptively exploring the design space. This computational methodology delivers a structured, systematic process that replaces traditional, inefficient trial-and-error calculations when investigators plan intricate medical experiments.

Operationally, the package requires users to program a custom simulation function that generates a complete experimental scenario and outputs an unambiguous binary indicator reflecting trial success or failure. The system interfaces with these user-defined functions through two primary computational wrappers, designated adsasi_0d and adsasi_1d. These functions iteratively evaluate candidate sample sizes across successive stages to establish how sample numbers directly influence empirical statistical power.

To characterize the relationship between sample size and empirical power, adsasi fits a modified probit regression model that incorporates custom simulation-wise partial likelihoods, analytical gradients, and exact Hessian matrices. By applying the Cramér-Rao approximation, the algorithm derives standard errors to quantify estimation uncertainty. Within this setup, adsasi_0d calculates the necessary sample size for fixed experimental designs, while adsasi_1d simultaneously evaluates one tunable design parameter alongside the required sample size to optimize study parameters.

The software was validated against benchmark scenarios possessing established analytical solutions, specifically equal and unequal allocation two-sample t-tests, as well as complex experimental settings lacking closed-form expressions. Across these tests, empirical sample size estimates derived by adsasi closely matched known analytical solutions within expected Monte Carlo variability. Furthermore, the wrapper routines progressively concentrate computational effort near the target region, markedly enhancing workflow efficiency relative to user-driven guess-and-check procedures.

In multivariable evaluations, adsasi_1d successfully captured intractable relationships between sample sizes and design parameters, locating an optimum close to the analytical solution whenever an analytical solution existed. Because the package imposes very few restrictions on the underlying simulation functions, users can assess diverse trial structures. Permissible setups include multistage decision rules, simultaneous endpoint requirements, rank-based statistical analyses, and bootstrap resampling conducted on observational clinical datasets.

To assist researchers throughout optimization runs, adsasi outputs real-time diagnostic metrics and uncertainty estimates that allow users to evaluate convergence and monitor statistical model stability. Overall, the package delivers a general and flexible computational framework for simulation-based sample size determination where analytical approaches remain impractical. By streamlining the planning of complex or unusual trials and experiments, the open-source software aims to accelerate their eventual clinical implementation.

Subject of Research: Simulation-based sample size estimation and clinical trial design optimization in R

Article Title: A simulations-first approach to sample sizes and design optimization with R package adsasi

Article References: Haviari, S. (2026). A simulations-first approach to sample sizes and design optimization with R package adsasi. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-026-03033-6

Image Credits: AI Generated

DOI: 10.1186/s12874-026-03033-6

Keywords: adsasi, sample size determination, clinical trial design, simulation-first optimization, empirical power, probit regression, partial likelihoods, Cramer-Rao approximation, adsasi_0d, adsasi_1d, Monte Carlo variability, two-sample t-test, multistage decision rules, simultaneous endpoints, rank-based analysis, bootstrap sampling

News Source: Ophelia Keating. (November 20, 2026). R Package Adsasi Optimizes Clinical Trial Sample Sizes via Adaptive Simulation. Scienmag.

Tags: adsasiadsasi_0dadsasi_1dbootstrap samplingClinical trial designCramer-Rao approximationempirical powerMonte Carlo variabilitymultistage decision rulespartial likelihoodsProbit regressionrank-based analysisSample Size Determinationsimulation-first optimizationsimultaneous endpointstwo-sample t-test
Share12Tweet7Share2ShareShareShare1

Related Posts

Leadership Support and Adapted Workflows Shape Rural Wisconsin Police Deflection Programs

Leadership Support and Adapted Workflows Shape Rural Wisconsin Police Deflection Programs

November 22, 2026
Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

November 22, 2026

Depression and Parkinson’s Associated With Greatest Quality of Life Reductions in Finland

November 22, 2026

Ugandan Parasite Surveillance Shows Complex Expansion of Pyrimethamine Resistance Mutation

November 22, 2026

POPULAR NEWS

  • Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

    Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

    29 shares
    Share 12 Tweet 7
  • Depression and Parkinson’s Associated With Greatest Quality of Life Reductions in Finland

    29 shares
    Share 12 Tweet 7
  • Ugandan Parasite Surveillance Shows Complex Expansion of Pyrimethamine Resistance Mutation

    29 shares
    Share 12 Tweet 7
  • Dual Immunotherapy Before Surgery Boosts T Cells in Recurrent Glioblastoma

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Leadership Support and Adapted Workflows Shape Rural Wisconsin Police Deflection Programs

Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

Depression and Parkinson’s Associated With Greatest Quality of Life Reductions in Finland

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.